BackArecor Therapeutics plc Overview
Arecor Therapeutics plc

Arecor Therapeutics plc PEG Ratio

Arecor Therapeutics plc (AREC.L) has a PEG ratio of 767.22, above the Healthcare sector average of 11.77.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

767.22

PEG Ratio

767.22

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Arecor Therapeutics plc (AREC.L) FAQ

As of the most recent data, AREC.L shows a PEG ratio of 767.22. That is above the Healthcare sector average of 11.77. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 11.77. Arecor Therapeutics plc is at 767.22, which is higher that average. That is roughly 6417.2% above the sector mean. Use the comparison chart on this page to see how AREC.L stacks up against individual peers as well.

Investors watch AREC.L's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Arecor Therapeutics plc's latest reading is 767.22. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Arecor Therapeutics plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 767.22) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 11.77, while AREC.L is at 767.22. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.